Bangladesh aprueba el uso de emergencia de la vacuna Covid-19 Pfizer

La Dirección General de Administración de Medicamentos (DGDA) aprobó hoy el uso de emergencia de la vacuna Pfizer mRNA Covid-19 en el país.

El regulador otorgó la Autorización de Uso de Emergencia (EUA) después de todos los exámenes necesarios por parte del comité, dijo un comunicado de prensa, firmado por el Mayor General Md Mahbubur Rahman, Director General de la DGDA.

Producida por Pfizer Manufacturing Belgium NV, esta es la cuarta vacuna Covid-19 aprobada para uso de emergencia en Bangladesh.

Las otras vacunas aprobadas son: Covishield producida por Serum Institute of India, Sputnik V producida por Generium Joint Stock Company de Rusia y Sinopharm producida por Beijing Institute of Biological Products Co. Ltd de China.


Source: BD24Live.com by www.bd24live.com.

*The article has been translated based on the content of BD24Live.com by www.bd24live.com. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!